FindTrial
Sign In

To study the effect of Durvadi Ghrita uttarabasti (a local treatment through vagina) and oral administration of Indrayava Choorna in management of excessive and irregular uterine bleeding.

Single arm trial to assess the efficacy of Durvadi Ghrita Uttarbasti and oral administration of Indrayava Choorna in management of Raktpradar.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029183
Enrollment
50
Registered
2020-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

Intervention1: Single arm trial. Durvadi Ghrita Uttarbasti and oral administration of Indrayava choorna.: 50 patients with complaints of excessive bleeding during menstruation , irregularly irregular

Sponsors

Dr Taware Smritika Mohanrao
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Married women 2.All patients with complaints of excessive bleeding during menstruation , irregularly irregular bleeding due to DUB, uterine fibroid less than 3cm and adenomyosis. 3.Mild, moderate and severe yonigata Raktasrava wiith sarvadehik lakshanas. 4.Patients with Raktapradar for a period of 2-3 cycles.

Exclusion criteria

Exclusion criteria: 1.Raktapradar with asadhya lakshanas. 2.patients suffeering from uterine fibroid more than 3cm, large ovarian cyst ,uterine or cervical malignancy, Yoni Arsha i.e cervical polyp. 3.Per vaginal bleeding due to trauma. 4.Patients suffering from blood dyscrasias.

Design outcomes

Primary

MeasureTime frame
To assess the effect of Durvadi Ghrita Uttarbasti and oral administration of Indrayava choorna on Raktapradar.Timepoint: Durvadi Ghrita Uttarbasti will be done for 3 consecutive days when bleeding stops in 3 to 5 ml of dose, along with this oral administration of Indrayava choorna for 7 days in 6gm BD dose irrespective of bleeding will be given. ( assesment will be done per month for 3 months)—

Secondary

MeasureTime frame
1.To study clinically the role of "Raktapitta chikitsa" in treatment of Raktapradar. 2.To study literary aspect of " Rakta Pradara" according to Ayurveda. 3.To note adverse reactions of the formulations and procedure if any. 4.To study the effect of treatment on bleeding in DUB ,fibroid uterus and adenomyosis. 5.Recurrence of disease and apunarbhav chikitsa will be observed .Timepoint: Duration of study is 3 months. 1st follow up will be taken after 15 days. 2nd follow up will be taken after next menses assessment will be done and treatment will be continued even if there is reduction in signs and symptoms. 3rd follow up after next menses if there is substantial reduction in symptoms treatment will be discontinued or else repeated for third cycle also.—

Countries

India

Contacts

Public ContactDr Taware Smritika Mohanrao

Dr.D.Y.Patil college of Ayurveda and research centre ,pimpri

neetamahesekar19@gmail.com9553965891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026